These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1081055)

  • 1. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma.
    Takehara K; Kikuchi K; Soma Y; Igarashi A; Ishibashi Y
    Arch Dermatol; 1990 Oct; 126(10):1368. PubMed ID: 2221947
    [No Abstract]   [Full Text] [Related]  

  • 4. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
    Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA
    Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scleroderma in children (author's transl)].
    Posternak F; Orusco M
    Schweiz Rundsch Med Prax; 1974 Jul; 63(30):913-21. PubMed ID: 4547092
    [No Abstract]   [Full Text] [Related]  

  • 10. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumscribed scleroderma with immunologic evidence of systemic lupus erythematosus.
    Mitchell AJ; Rusin LJ; Diaz LA
    Arch Dermatol; 1980 Jan; 116(1):69-73. PubMed ID: 6153258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma.
    Serup J; Staun-Olsen P
    Allergy; 1986 Aug; 41(6):452-6. PubMed ID: 3491549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proof of serum antibodies against single stranded DNA in progressive scleroderma using the Farr technic].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Monatsschr; 1975 May; 161(5):364-9. PubMed ID: 1183663
    [No Abstract]   [Full Text] [Related]  

  • 14. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
    Asano Y; Sato S
    Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
    [No Abstract]   [Full Text] [Related]  

  • 15. High titers of antibodies to single-stranded DNA in linear scleroderma.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1985 Mar; 121(3):345-7. PubMed ID: 3883904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Types of anticellular structure antisera in scleroderma patients].
    Ni ZM
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research].
    Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scleroderma].
    Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
    Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized scleroderma is an autoimmune disorder.
    Takehara K; Sato S
    Rheumatology (Oxford); 2005 Mar; 44(3):274-9. PubMed ID: 15561734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.